MEET YOUR MATCH - VC career path
Wednesday, February 18, 13:30 - 14:15
Michael Vlemmix | Partner at GIMV Life Sciences
Michaël is a Bio-Engineer (Cell & Gene Biotechnology) holding a Master in Management from the Antwerp Management School. He started his professional career in 2012 at a medical device spin-off of the University of Antwerp. After three years, he continued his career in investment banking at KBC Securities as a Biotech/Healthcare research analyst where he worked on initial public offerings and several other capital market transactions while providing coverage of the Benelux Biotech & Healthcare stocks. Late 2017, Michaël joined the Gimv Life Sciences team focusing on venture capital investments. Today he is representing Gimv on the board of directors of Kivu Therapeutics (US), Complement Therapeutics (DE/UK), Onera Health (NL) and FIRE1 (IE).
About Gimv
Gimv is a European investment company, listed on Euronext Brussels. With 40 years' experience in private equity and venture capital, Gimv currently has EUR 2 billion of assets under management. The portfolio contains around 60 portfolio companies, with combined turnover of EUR 3.1 billion and more than 19,000 employees.As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial, innovative companies with high growth potential and supports them in their transformation into market leaders. Gimv's five investment platforms are Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities. Each platform works with an experienced team across Gimv’s home markets of Benelux, France and DACH, supported by an extended international network of experts.
| Powered by: BCF Courses BV | Connect with us | Join BioBusiness Winter School | |||
| Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | Register |
| © Copyright 2021 by BCF Courses |